Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth D Thompson

Showing results (61-70 of 91) with videos related to

Pageof 10
Sort By:
Biorxiv : the Preprint Server for Biology|August 16, 2024
3D histology reveals that immune response to pancreatic precancers is heterogeneous and depends on global pancreas structureAshley L Kiemen, Cristina Almagro-Pérez, Valentina Matos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 28, 2020
A Phase II Study of Allogeneic GM-CSF-Transfected Pancreatic Tumor Vaccine (GVAX) with Ipilimumab as Maintenance Treatment for Metastatic Pancreatic CancerAnnie A Wu, Katherine M Bever, Won Jin Ho, et al.
Cell Press Blue|June 22, 2026
Quantitative 3D histology reveals localized immune remodeling during early pancreatic cancer progressionAshley L Kiemen, Valentina Matos, Cristina Almagro-Pérez, et al.
Science Advances|February 7, 2024
Neoadjuvant radioimmunotherapy in pancreatic cancer enhances effector T cell infiltration and shortens their distances to tumor cellsJunke Wang, Jessica Gai, Tengyi Zhang, et al.
Cancer Medicine|December 27, 2019
A phase 2 study of GVAX colon vaccine with cyclophosphamide and pembrolizumab in patients with mismatch repair proficient advanced colorectal cancerMark Yarchoan, Chiung-Yu Huang, Qingfeng Zhu, et al.
Journal for Immunotherapy of Cancer|May 22, 2021
Pathways of immune exclusion in metastatic osteosarcoma are associated with inferior patient outcomesJohn A Ligon, Woonyoung Choi, Gady Cojocaru, et al.
Gastroenterology|June 9, 2019
Intraductal Papillary Mucinous Neoplasms Arise From Multiple Independent Clones, Each With Distinct MutationsCatherine G Fischer, Violeta Beleva Guthrie, Alicia M Braxton, et al.
International Journal of Surgery (London, England)|February 17, 2023
Cancer-cell-derived sialylated IgG as a novel biomarker for predicting poor pathological response to neoadjuvant therapy and prognosis in pancreatic cancerMing Cui, Sami Shoucair, Quan Liao, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 26, 2024
Concordance of Whole-Slide Imaging and Conventional Light Microscopy for Assessment of Pathologic Response Following Neoadjuvant Therapy for Lung CancerJulie S Deutsch, Daphne Wang, Krista Y Chen, et al.
Surgery|August 14, 2025
The impact of perioperative chemotherapy in patients with pancreatic adenosquamous carcinomaBrady A Campbell, Joseph R Habib, Benedict Kinny-Köster, et al.
Pageof 10

Showing results (61-70 of 91) with videos related to

Sort By:
Pageof 10
Biorxiv : the Preprint Server for Biology|August 16, 2024
3D histology reveals that immune response to pancreatic precancers is heterogeneous and depends on global pancreas structureAshley L Kiemen, Cristina Almagro-Pérez, Valentina Matos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 28, 2020
A Phase II Study of Allogeneic GM-CSF-Transfected Pancreatic Tumor Vaccine (GVAX) with Ipilimumab as Maintenance Treatment for Metastatic Pancreatic CancerAnnie A Wu, Katherine M Bever, Won Jin Ho, et al.
Cell Press Blue|June 22, 2026
Quantitative 3D histology reveals localized immune remodeling during early pancreatic cancer progressionAshley L Kiemen, Valentina Matos, Cristina Almagro-Pérez, et al.
Science Advances|February 7, 2024
Neoadjuvant radioimmunotherapy in pancreatic cancer enhances effector T cell infiltration and shortens their distances to tumor cellsJunke Wang, Jessica Gai, Tengyi Zhang, et al.
Cancer Medicine|December 27, 2019
A phase 2 study of GVAX colon vaccine with cyclophosphamide and pembrolizumab in patients with mismatch repair proficient advanced colorectal cancerMark Yarchoan, Chiung-Yu Huang, Qingfeng Zhu, et al.
Journal for Immunotherapy of Cancer|May 22, 2021
Pathways of immune exclusion in metastatic osteosarcoma are associated with inferior patient outcomesJohn A Ligon, Woonyoung Choi, Gady Cojocaru, et al.
Gastroenterology|June 9, 2019
Intraductal Papillary Mucinous Neoplasms Arise From Multiple Independent Clones, Each With Distinct MutationsCatherine G Fischer, Violeta Beleva Guthrie, Alicia M Braxton, et al.
International Journal of Surgery (London, England)|February 17, 2023
Cancer-cell-derived sialylated IgG as a novel biomarker for predicting poor pathological response to neoadjuvant therapy and prognosis in pancreatic cancerMing Cui, Sami Shoucair, Quan Liao, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 26, 2024
Concordance of Whole-Slide Imaging and Conventional Light Microscopy for Assessment of Pathologic Response Following Neoadjuvant Therapy for Lung CancerJulie S Deutsch, Daphne Wang, Krista Y Chen, et al.
Surgery|August 14, 2025
The impact of perioperative chemotherapy in patients with pancreatic adenosquamous carcinomaBrady A Campbell, Joseph R Habib, Benedict Kinny-Köster, et al.
Pageof 10